[
  {
    "objectID": "directory.html",
    "href": "directory.html",
    "title": "Website Directory",
    "section": "",
    "text": "These are other websites across Steno Aarhus:\n\nOfficial site: The official Region Midt website for more general public information and details.\nResearch Common Docs: Common documents and operating prodecures for researchers across Steno Aarhus.\nEpidemiology and Statistics: Events and activities related to epidemiology and statistics.\nRegister Research Space: Events and activities related to register-based research.\nInternationalization: Efforts to spread knowledge and connect with other countries, specifically Latin America.\nEpidemiology Group: Documentation for meetings within the epidemiology group.\nCoding Cafe: Schedule for in-person coding support and help."
  },
  {
    "objectID": "about/index.html",
    "href": "about/index.html",
    "title": "StenoVoice",
    "section": "",
    "text": "StenoVoice er et forskningsprojekt ved Steno Diabetes Center Aarhus, der unders√∏ger, hvordan stemmen kan anvendes som en digital biomark√∏r til at forudsige og overv√•ge diabetesrelaterede komplikationer. Ved hj√¶lp af avancerede metoder inden for kunstig intelligens og maskinl√¶ring analyserer vi stemmeoptagelser for at identificere karakteristika i stemmen, der kan afspejle helbredstilstande s√•som hjertekarsygdomme, diabetisk neuropati og diabetesrelateret stress.\nDiabetes kan p√•virke flere organer og funktioner, som er centrale for stemmeproduktionen ‚Äì herunder nerver og muskler, der styrer strubehovedet og √•ndedr√¶ttet. Tidligere studier har vist, at personer med type 2-diabetes kan opleve √¶ndringer i stemmekvalitet, fx h√¶shed og stemmetr√¶thed, hvilket kan v√¶re relateret til d√•rlig glyk√¶misk kontrol eller tilstedev√¶relse af neuropati."
  },
  {
    "objectID": "about/index.html#baggrund-og-vision",
    "href": "about/index.html#baggrund-og-vision",
    "title": "StenoVoice",
    "section": "",
    "text": "StenoVoice er et forskningsprojekt ved Steno Diabetes Center Aarhus, der unders√∏ger, hvordan stemmen kan anvendes som en digital biomark√∏r til at forudsige og overv√•ge diabetesrelaterede komplikationer. Ved hj√¶lp af avancerede metoder inden for kunstig intelligens og maskinl√¶ring analyserer vi stemmeoptagelser for at identificere karakteristika i stemmen, der kan afspejle helbredstilstande s√•som hjertekarsygdomme, diabetisk neuropati og diabetesrelateret stress.\nDiabetes kan p√•virke flere organer og funktioner, som er centrale for stemmeproduktionen ‚Äì herunder nerver og muskler, der styrer strubehovedet og √•ndedr√¶ttet. Tidligere studier har vist, at personer med type 2-diabetes kan opleve √¶ndringer i stemmekvalitet, fx h√¶shed og stemmetr√¶thed, hvilket kan v√¶re relateret til d√•rlig glyk√¶misk kontrol eller tilstedev√¶relse af neuropati."
  },
  {
    "objectID": "about/index.html#forskningsm√•l-og-studier",
    "href": "about/index.html#forskningsm√•l-og-studier",
    "title": "StenoVoice",
    "section": "Forskningsm√•l og studier",
    "text": "Forskningsm√•l og studier\nProjektet er organiseret i tre hovedstudier med hver deres specifikke forskningssp√∏rgsm√•l:\n\nVokale biomark√∏rer for hjertekarsygdomme\nForm√•let med dette studie er at identificere og validere vokale biomark√∏rer, der kan forudsige hjertekarsygdomme. Data stammer fra stemmeoptagelser og kliniske oplysninger fra den regionale kohorte Helbred Midt, samt stemmeoptagelser og kliniske oplysninger fra sammedagsscreenning p√• hospitalet.\nVokale biomark√∏rer for diabetisk neuropati\nDette studie unders√∏ger, hvorvidt diabetisk neuropati p√•virker stemmen hos personer med type 1 og type 2-diabetes, og om disse √¶ndringer i stemmen kan identificeres uafh√¶ngigt af andre kendte risikofaktorer.\nVokale biomark√∏rer til vurdering af diabetesrelateret stress\nHer anvendes en multimodal tilgang til at identificere sproglige og vokale signaler p√• diabetesrelateret stress. Deltagerne besvarer √•bne sp√∏rgsm√•l om deres liv med diabetes, og b√•de stemme og indhold analyseres."
  },
  {
    "objectID": "about/index.html#dataindsamling-og-anvendte-metoder",
    "href": "about/index.html#dataindsamling-og-anvendte-metoder",
    "title": "StenoVoice",
    "section": "Dataindsamling og anvendte metoder",
    "text": "Dataindsamling og anvendte metoder\nDeltagerne udf√∏rer forskellige stemmeopgaver, herunder:\n\nAt l√¶se en kort tekst h√∏jt\n\nAt t√¶lle fra 1 til 20\n\nAt sige en lang ‚Äòaaa‚Äô-lyd\n\nAt gentage stavelserne Pa-Ta-Ka hurtigt i 10 sekunder\n\nAt besvare √•bne sp√∏rgsm√•l med egne ord\n\nOptagelserne analyseres ved hj√¶lp af moderne metoder inden for kunstig intelligens og maskinl√¶ring. Vi afpr√∏ver forskellige tekniske tilgange og repr√¶sentationer af stemmen (f.eks. spektrogrammer og embeddings) for at udvikle de mest informative og robuste vokale biomark√∏rer."
  },
  {
    "objectID": "about/index.html#fremtidsperspektiver-og-klinisk-anvendelse",
    "href": "about/index.html#fremtidsperspektiver-og-klinisk-anvendelse",
    "title": "StenoVoice",
    "section": "Fremtidsperspektiver og klinisk anvendelse",
    "text": "Fremtidsperspektiver og klinisk anvendelse\nStenoVoice har potentiale til at bidrage v√¶sentligt til fremtidens sundhedsv√¶sen. Vokale biomark√∏rer er:\n\nIkke-invasive\n\nLet tilg√¶ngelige\n\nBillige at indsamle\n\nVelegnede til brug i b√•de klinik og hjemmemilj√∏\n\nTeknologien kan underst√∏tte tidlig opsporing af komplikationer, rettidig indsats og mere personligt tilpassede behandlingsforl√∏b. Vi ser ogs√• muligheder for at udvide brugen af vokale biomark√∏rer til andre sygdomsomr√•der, hvor stemmen kan afspejle √¶ndringer i helbredet."
  },
  {
    "objectID": "about/index.html#kontakt-og-projektledelse",
    "href": "about/index.html#kontakt-og-projektledelse",
    "title": "StenoVoice",
    "section": "Kontakt og projektledelse",
    "text": "Kontakt og projektledelse\nProjektleder:\nAdam Hulman, Lektor\nadahul@rm.dk\nPh.d.-studerende:\nManuel Thomasen\nmanuth@rm.dk / manuth@ph.au.dk"
  },
  {
    "objectID": "about/index.html#protokol",
    "href": "about/index.html#protokol",
    "title": "StenoVoice",
    "section": "Protokol",
    "text": "Protokol\nDu kan l√¶se mere om projektets design og metoder i vores forskningsprotokol:\nüìÑ Download StenoVoice-protokol (PDF)"
  },
  {
    "objectID": "index.html#form√•l",
    "href": "index.html#form√•l",
    "title": "Velkommen til StenoVoice",
    "section": "Form√•l",
    "text": "Form√•l\nStenoVoice er et forskningsprojekt ved Steno Diabetes Center Aarhus og Aarhus Universitet, hvor vi unders√∏ger, om stemmen kan bruges som et v√¶rkt√∏j til at forudsige komplikationer og overv√•ge sygdomsudvikling hos personer med diabetes ‚Äì f.eks. hjertekarsygdomme og nerveskader. Ved hj√¶lp af kunstig intelligens og maskinl√¶ring analyserer vi stemmeoptagelser for at identificere vokale biomark√∏rer ‚Äì karakteristika i stemmen, der afspejler helbredstilstand."
  },
  {
    "objectID": "index.html#hvorfor-udvikler-vi-metoder-der-benytter-stemmen",
    "href": "index.html#hvorfor-udvikler-vi-metoder-der-benytter-stemmen",
    "title": "Velkommen til StenoVoice",
    "section": "Hvorfor udvikler vi metoder, der benytter stemmen?",
    "text": "Hvorfor udvikler vi metoder, der benytter stemmen?\nTraditionelle metoder til risikovurdering af hjertekarsygdomme bygger prim√¶rt p√• statiske oplysninger som alder, k√∏n, livsstil, langtidsblodsukker, diabetesvarighed og blodtryk. Men kan disse metoder forbedres ved at inddrage nye datatyper ‚Äì som stemmen?\nStemmen afspejler helbredet. Hvis organerne som er med til at producere stemmen, bliver p√•virket af en tilstand, sygdom eller forv√¶ring, kan det observeres i signalet fra stemmen. Vi tror derfor p√•, at stemmen rummer v√¶rdifuld information, der kan bruges til at forbedre eksisterende metoder til sygdomsopsporing og -overv√•gning.\nOptagelse af stemmen er let og tilg√¶ngelig. De fleste har en smartphone eller computer, hvilket g√∏r det muligt at optage stemmen hvor som helst og n√•r som helst. Stemmen som datakilde √•bner derfor op for fleksible og ressourceeffektive l√∏sninger.\nDenne teknologi kan bidrage til en mere tilg√¶ngelig sundhedsindsats med:\n\nTidlig sygdomsopsporing\n\nRettidig behandling\n\n√òget tryghed i hverdagen\n\nRessourceoptimering i sundhedsv√¶senet\n\nMulighed for skalering til st√∏rre befolkningsgrupper og andre sygdomsomr√•der"
  },
  {
    "objectID": "index.html#hvordan-deltager-man",
    "href": "index.html#hvordan-deltager-man",
    "title": "Velkommen til StenoVoice",
    "section": "Hvordan deltager man?",
    "text": "Hvordan deltager man?\nDeltagelse i StenoVoice-projektet kan ske p√• to m√•der:\n\n1. StenoVoice (fysisk deltagelse)\nP√• Steno Diabetes Center Aarhus, Aarhus Universitetshospital, Palle Juul-Jensens Boulevard 11, Indgang A, 8200 Aarhus N har vi opstillet en lydt√¶t ‚Äúmutebox‚Äù, hvor man kan bidrage til projektet ved at optage sin stemme. Deltagelse sker i forbindelse med et planlagt bes√∏g, f.eks. √•rssamtale eller sammedagsscreening.\nVed ankomst henvender man sig til en medarbejder, som hj√¶lper med at starte forl√∏bet. Herefter g√•r man ind i boksen, udfylder et sp√∏rgeskema, laver en r√¶kke stemme√∏velser og svarer p√• sp√∏rgsm√•l ved at indtale svarene.\nOplysninger fra sp√∏rgeskemaet, sammedagsscreeningen og de danske registre kombineres med stemmeoptagelserne og danner grundlag for udviklingen af vokale biomark√∏rer.\nSe videoen nedenfor for at f√• indblik i, hvordan deltagelsen foreg√•r:\n[Video-link]\n\n\n2. StenoVoice Helbred Midt (online deltagelse)\nVi inviterer personer fra Helbred Midt-kohorten til at deltage i en online unders√∏gelse. Invitationen sendes via e-Boks, og deltagerne bedes besvare et sp√∏rgeskema og uploade stemmeoptagelser fra hjemmet.\nOgs√• her anvendes information fra sp√∏rgeskemaet og de danske registre sammen med stemmeoptagelserne til at identificere vokale biomark√∏rer.\nSe videoen nedenfor for at f√• indblik i online-deltagelsen:\n[Video-link]"
  },
  {
    "objectID": "index.html#fremtidsperspektiver",
    "href": "index.html#fremtidsperspektiver",
    "title": "Velkommen til StenoVoice",
    "section": "Fremtidsperspektiver",
    "text": "Fremtidsperspektiver\nI fremtiden h√•ber vi, at teknologier som StenoVoice kan anvendes bredt i klinisk praksis som en del af regelm√¶ssige sundhedstjek. Vi ser ogs√• et stort potentiale i at udvide teknologien til andre sygdomsomr√•der, hvor vokale biomark√∏rer kan bidrage til tidlig diagnostik og bedre risikovurdering."
  },
  {
    "objectID": "index.html#kontakt",
    "href": "index.html#kontakt",
    "title": "Velkommen til StenoVoice",
    "section": "Kontakt",
    "text": "Kontakt\nPI: Adam Hulman, Associate Professor\nadahul@rm.dk\nProjektansvarlig og Ph.d.-studerende: Manuel Thomasen\nmanuth@rm.dk / manuth@ph.au.dk"
  },
  {
    "objectID": "StenoVoice-HICD/index.html",
    "href": "StenoVoice-HICD/index.html",
    "title": "StenoVoice-HICD",
    "section": "",
    "text": "Your browser does not support the video tag. \n:::"
  },
  {
    "objectID": "SOP/index.html",
    "href": "SOP/index.html",
    "title": "SOP: Deltagerforl√∏b i StenoVoice",
    "section": "",
    "text": "Dette dokument beskriver den standardiserede procedure for gennemf√∏relse af deltagerforl√∏bet i StenoVoice i forbindelse med stemmeoptagelser og sp√∏rgeskemaudfyldelse."
  },
  {
    "objectID": "SOP/index.html#modtagelse-og-introduktion",
    "href": "SOP/index.html#modtagelse-og-introduktion",
    "title": "SOP: Deltagerforl√∏b i StenoVoice",
    "section": "5.1 Modtagelse og introduktion",
    "text": "5.1 Modtagelse og introduktion\n\nDeltageren henvender sig til en medarbejder ved ankomst.\n\nMedarbejderen byder velkommen og giver en kort introduktion til projektet og forl√∏bet i Muteboxen.\n\nDeltageren f√∏lges ind i Muteboxen og s√¶tter sig til rette."
  },
  {
    "objectID": "SOP/index.html#instruktion",
    "href": "SOP/index.html#instruktion",
    "title": "SOP: Deltagerforl√∏b i StenoVoice",
    "section": "5.2 Instruktion",
    "text": "5.2 Instruktion\n\nMedarbejderen instruerer deltageren i f√∏lgende:\n\nHvordan sp√∏rgeskemaet √•bnes og udfyldes\n\nHvordan stemmeoptagelser gennemf√∏res\n\nKorrekt placering og brug af mikrofon og headset"
  },
  {
    "objectID": "SOP/index.html#gennemf√∏relse",
    "href": "SOP/index.html#gennemf√∏relse",
    "title": "SOP: Deltagerforl√∏b i StenoVoice",
    "section": "5.3 Gennemf√∏relse",
    "text": "5.3 Gennemf√∏relse\n\nDeltageren udfylder sp√∏rgeskemaet p√• sk√¶rmen.\n\nDeltageren gennemf√∏rer herefter f√∏lgende stemmeopgaver:\n\nL√¶s en kort tekst h√∏jt\n\nSig vokallyden ‚ÄúAaaaaa‚Äù s√• l√¶nge som muligt p√• √©t √•ndedrag i normalt lydniveau\n\nT√¶l h√∏jt fra 1 til 20\n\nGentag stavelserne PaTaKa s√• mange gange som muligt i 10 sekunder\n\nBeskriv livet med diabetes i frit tale\n\nSvar p√• √©t eller flere √•bne sp√∏rgsm√•l, fx: (opdateres)\n\n‚ÄúHvordan var dit bes√∏g p√• Steno Centeret i dag?‚Äù\n\nAndre valgfri sp√∏rgsm√•l, efter behov"
  },
  {
    "objectID": "SOP/index.html#afslutning",
    "href": "SOP/index.html#afslutning",
    "title": "SOP: Deltagerforl√∏b i StenoVoice",
    "section": "5.4 Afslutning",
    "text": "5.4 Afslutning\n\nN√•r alle opgaver er gennemf√∏rt, informeres deltageren om, at forl√∏bet er afsluttet.\n\nDeltageren forlader Muteboxen.\n\nMedarbejderen sikrer, at Muteboxen ryddes og klarg√∏res til n√¶ste deltager."
  },
  {
    "objectID": "participants/index.html",
    "href": "participants/index.html",
    "title": "For Deltagere",
    "section": "",
    "text": "StenoVoice er et forskningsprojekt ved Steno Diabetes Center Aarhus, hvor vi unders√∏ger, om stemmen kan bruges til at sige noget om helbredet hos personer med og uden diabetes. Ved at analysere stemmeoptagelser med hj√¶lp fra kunstig intelligens h√•ber vi at kunne udvikle nye, ikke-invasive metoder til at opdage sygdomme som hjertekarsygdom, neuropati og diabetesrelateret stress."
  },
  {
    "objectID": "participants/index.html#hvad-er-stenovoice",
    "href": "participants/index.html#hvad-er-stenovoice",
    "title": "For Deltagere",
    "section": "",
    "text": "StenoVoice er et forskningsprojekt ved Steno Diabetes Center Aarhus, hvor vi unders√∏ger, om stemmen kan bruges til at sige noget om helbredet hos personer med og uden diabetes. Ved at analysere stemmeoptagelser med hj√¶lp fra kunstig intelligens h√•ber vi at kunne udvikle nye, ikke-invasive metoder til at opdage sygdomme som hjertekarsygdom, neuropati og diabetesrelateret stress."
  },
  {
    "objectID": "participants/index.html#hvad-indeb√¶rer-det-at-deltage",
    "href": "participants/index.html#hvad-indeb√¶rer-det-at-deltage",
    "title": "For Deltagere",
    "section": "Hvad indeb√¶rer det at deltage?",
    "text": "Hvad indeb√¶rer det at deltage?\nSom deltager i StenoVoice bliver du bedt om at udf√∏re nogle korte stemmeopgaver. Det kan f.eks. v√¶re:\n\nAt sige ‚Äúaaaah‚Äù s√• l√¶nge du kan\n\nAt t√¶lle h√∏jt fra 1 til 20\n\nAt l√¶se en kort tekst h√∏jt\n\nAt gentage stavelser som Pa-Ta-Ka i 10 sekunder\n\nAt tale frit om, hvordan det er at leve med diabetes\n\nAfh√¶ngigt af hvilken del af projektet du deltager i, kan stemmeoptagelserne enten blive foretaget p√• hospitalet eller hjemme via din mobiltelefon eller computer."
  },
  {
    "objectID": "participants/index.html#hvorfor-er-din-deltagelse-vigtig",
    "href": "participants/index.html#hvorfor-er-din-deltagelse-vigtig",
    "title": "For Deltagere",
    "section": "Hvorfor er din deltagelse vigtig?",
    "text": "Hvorfor er din deltagelse vigtig?\nDiabetes kan p√•virke kroppen p√• mange m√•der ‚Äì ogs√• de dele, vi bruger til at tale med. Ved at indsamle stemmeoptagelser fra mange forskellige mennesker kan vi unders√∏ge, om der er bestemte m√∏nstre i stemmen, som h√¶nger sammen med helbredstilstanden. Din stemme er med til at give forskningen en st√¶rkere stemme.\nVed at deltage bidrager du til forskning, der kan g√∏re fremtidens behandling af diabetes mere pr√¶cis, personlig og tilg√¶ngelig ‚Äì ogs√• for dem, der bor langt v√¶k fra hospitalet."
  },
  {
    "objectID": "participants/index.html#hvem-kan-deltage",
    "href": "participants/index.html#hvem-kan-deltage",
    "title": "For Deltagere",
    "section": "Hvem kan deltage?",
    "text": "Hvem kan deltage?\nVi inviterer b√•de personer med og uden diabetes til at deltage i projektet. Du beh√∏ver ikke nogen s√¶rlige foruds√¶tninger, og det tager kun f√• minutter at udf√∏re stemmeopgaverne.\nHvis du har f√•et en invitation, kan du trygt f√∏lge instruktionerne i beskeden. Har du sp√∏rgsm√•l, er du meget velkommen til at kontakte os."
  },
  {
    "objectID": "participants/index.html#kontakt",
    "href": "participants/index.html#kontakt",
    "title": "For Deltagere",
    "section": "Kontakt",
    "text": "Kontakt\nPh.d.-studerende:\nManuel Thomasen\nmanuth@rm.dk / manuth@ph.au.dk"
  },
  {
    "objectID": "LICENSE.html",
    "href": "LICENSE.html",
    "title": "SDCA Research StenoVoice",
    "section": "",
    "text": "Attribution 4.0 International\n=======================================================================\nCreative Commons Corporation (‚ÄúCreative Commons‚Äù) is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an ‚Äúas-is‚Äù basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.\nUsing Creative Commons Public Licenses\nCreative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.\n Considerations for licensors: Our public licenses are\n intended for use by those authorized to give the public\n permission to use material in ways otherwise restricted by\n copyright and certain other rights. Our licenses are\n irrevocable. Licensors should read and understand the terms\n and conditions of the license they choose before applying it.\n Licensors should also secure all rights necessary before\n applying our licenses so that the public can reuse the\n material as expected. Licensors should clearly mark any\n material not subject to the license. This includes other CC-\n licensed material, or material used under an exception or\n limitation to copyright. More considerations for licensors:\nwiki.creativecommons.org/Considerations_for_licensors\n\n Considerations for the public: By using one of our public\n licenses, a licensor grants the public permission to use the\n licensed material under specified terms and conditions. If\n the licensor's permission is not necessary for any reason--for\n example, because of any applicable exception or limitation to\n copyright--then that use is not regulated by the license. Our\n licenses grant only permissions under copyright and certain\n other rights that a licensor has authority to grant. Use of\n the licensed material may still be restricted for other\n reasons, including because others have copyright or other\n rights in the material. A licensor may make special requests,\n such as asking that all changes be marked or described.\n Although not required by our licenses, you are encouraged to\n respect those requests where reasonable. More considerations\n for the public: \nwiki.creativecommons.org/Considerations_for_licensees\n=======================================================================\nCreative Commons Attribution 4.0 International Public License\nBy exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution 4.0 International Public License (‚ÄúPublic License‚Äù). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.\nSection 1 ‚Äì Definitions.\n\nAdapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.\nAdapter‚Äôs License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.\nCopyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.\nEffective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.\nExceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.\nLicensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.\nLicensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.\nLicensor means the individual(s) or entity(ies) granting rights under this Public License.\nShare means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.\nSui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.\nYou means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.\n\nSection 2 ‚Äì Scope.\n\nLicense grant.\n\nSubject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:\n\nreproduce and Share the Licensed Material, in whole or in part; and\nproduce, reproduce, and Share Adapted Material.\n\nExceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.\nTerm. The term of this Public License is specified in Section 6(a).\nMedia and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)\n\nnever produces Adapted Material.\n\nDownstream recipients.\n\nOffer from the Licensor ‚Äì Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.\nNo downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.\n\nNo endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).\n\nOther rights.\n\nMoral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.\nPatent and trademark rights are not licensed under this Public License.\nTo the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.\n\n\nSection 3 ‚Äì License Conditions.\nYour exercise of the Licensed Rights is expressly made subject to the following conditions.\n\nAttribution.\n\nIf You Share the Licensed Material (including in modified form), You must:\n\nretain the following if it is supplied by the Licensor with the Licensed Material:\n\nidentification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);\na copyright notice;\na notice that refers to this Public License;\na notice that refers to the disclaimer of warranties;\na URI or hyperlink to the Licensed Material to the extent reasonably practicable;\n\nindicate if You modified the Licensed Material and retain an indication of any previous modifications; and\nindicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.\n\nYou may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.\nIf requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.\nIf You Share Adapted Material You produce, the Adapter‚Äôs License You apply must not prevent recipients of the Adapted Material from complying with this Public License.\n\n\nSection 4 ‚Äì Sui Generis Database Rights.\nWhere the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:\n\nfor the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;\nif You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and\nYou must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.\n\nFor the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.\nSection 5 ‚Äì Disclaimer of Warranties and Limitation of Liability.\n\nUNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.\nTO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.\nThe disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.\n\nSection 6 ‚Äì Term and Termination.\n\nThis Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.\nWhere Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:\n\nautomatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or\nupon express reinstatement by the Licensor.\n\nFor the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.\nFor the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.\nSections 1, 5, 6, 7, and 8 survive termination of this Public License.\n\nSection 7 ‚Äì Other Terms and Conditions.\n\nThe Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.\nAny arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.\n\nSection 8 ‚Äì Interpretation.\n\nFor the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.\nTo the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.\nNo term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.\nNothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.\n\n=======================================================================\nCreative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the ‚ÄúLicensor.‚Äù The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark ‚ÄúCreative Commons‚Äù or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.\nCreative Commons may be contacted at creativecommons.org."
  },
  {
    "objectID": "researchers/index.html",
    "href": "researchers/index.html",
    "title": "Researchers",
    "section": "",
    "text": "The StenoVoice project is an interdisciplinary initiative aiming to develop and validate vocal biomarkers for the risk assessment of diabetes-related complications. By integrating deep learning methods with multimodal data, including voice, we aim to provide novel tools for predicting and monitoring cardiovascular disease (CVD), neuropathy, and diabetes distress in people with diabetes. Our research spans methodological innovation, clinical application, and collaboration across international partners.\n\n\n\n\nThis study focuses on:\n\nInitiating voice data collection nested in an existing population-based cohort, i.e., Health in Central Denmark (HICD), and to identify and validate vocal biomarkers for CVD in the general population.\n\n\n\n\nThis study seeks to:\n\nIdentify vocal biomarkers of neuropathy in people with type 1 diabetes (T1D) and type 2 diabetes (T2D).\n\n\n\n\nThis study aims to:\n\nDevelop a multimodal approach to detect diabetes distress based on voice recordings and audio transcriptions by people with T1D and T2D.\n\n\n\n\n\nWe use a multi-step approach to data processing and analysis:\n\nVoice Data: Preprocessing includes filtering, silence removal, noise reduction, framing, windowing, feature extraction, and feature selection, among other things.\nText Data: Natural language processing techniques are applied to transcribed responses.\nModeling: Predictive models include both classical machine learning and deep learning approaches.\n\n\n\n\nThe project is conducted in collaboration with:\n\nLuxembourg Institute of Health, with the involvement of Guy Fagherazzi, Director of the Department of Precision Health & Head of the ‚ÄúDeep Digital Phenotyping‚Äù Research Unit\nSteno Diabetes Center Copenhagen, with the involvement of Christian Stevns Hansen\n\n\n\n\n\nUpdated continuously\n\n\n\n\n\nPrincipal Investigator: Adam Hulman, Associate Professor at the Department of Public Health, Aarhus University & Senior Data Scientist at Steno Diabetes Center Aarhus\nPhD Student: Manuel Thomasen, Steno Diabetes Center Aarhus & Department of Public Health, Aarhus University\nAffiliated Lab: Machine Learning and Clinical Prediction HulmanLab, Steno Diabetes Center Aarhus.\n\n\n\n\n\nPreprint manuscripts will be available on [medRxiv / arXiv links].\nCode will be shared via GitHub.\n[Add links to relevant previous publications by team members.]\n\n\n\n\nFor questions or collaboration opportunities, please contact:\nAdam Hulman, Associate Professor\nadahul@rm.dk\nManuel Thomasen\nmanuth@rm.dk / manuth@ph.au.dk\nWe welcome researchers interested in digital health, vocal biomarkers, and diabetes epidemiology to reach out for collaboration or discussion.\n\n\n\nThis work was supported by a research grant from the Danish Diabetes and Endocrine Academy, funded by the Novo Nordisk Foundation (NNF22SA0079901), and the Danish Data Science Academy, funded by the Novo Nordisk Foundation (NNF21SA0069429), and by Steno Diabetes Center Aarhus which is partly funded by a donation from the Novo Nordisk Foundation (NNF17SA0031230), and by a Data Science Emerging Investigator grant (NNF22OC0076725) by the Novo Nordisk Foundation, and funds by Aarhus University, Department of Public Health."
  },
  {
    "objectID": "researchers/index.html#research-objectives",
    "href": "researchers/index.html#research-objectives",
    "title": "Researchers",
    "section": "",
    "text": "This study focuses on:\n\nInitiating voice data collection nested in an existing population-based cohort, i.e., Health in Central Denmark (HICD), and to identify and validate vocal biomarkers for CVD in the general population.\n\n\n\n\nThis study seeks to:\n\nIdentify vocal biomarkers of neuropathy in people with type 1 diabetes (T1D) and type 2 diabetes (T2D).\n\n\n\n\nThis study aims to:\n\nDevelop a multimodal approach to detect diabetes distress based on voice recordings and audio transcriptions by people with T1D and T2D."
  },
  {
    "objectID": "researchers/index.html#methodology",
    "href": "researchers/index.html#methodology",
    "title": "Researchers",
    "section": "",
    "text": "We use a multi-step approach to data processing and analysis:\n\nVoice Data: Preprocessing includes filtering, silence removal, noise reduction, framing, windowing, feature extraction, and feature selection, among other things.\nText Data: Natural language processing techniques are applied to transcribed responses.\nModeling: Predictive models include both classical machine learning and deep learning approaches."
  },
  {
    "objectID": "researchers/index.html#collaborations",
    "href": "researchers/index.html#collaborations",
    "title": "Researchers",
    "section": "",
    "text": "The project is conducted in collaboration with:\n\nLuxembourg Institute of Health, with the involvement of Guy Fagherazzi, Director of the Department of Precision Health & Head of the ‚ÄúDeep Digital Phenotyping‚Äù Research Unit\nSteno Diabetes Center Copenhagen, with the involvement of Christian Stevns Hansen"
  },
  {
    "objectID": "researchers/index.html#preliminary-work-and-feasibility",
    "href": "researchers/index.html#preliminary-work-and-feasibility",
    "title": "Researchers",
    "section": "",
    "text": "Updated continuously"
  },
  {
    "objectID": "researchers/index.html#research-team",
    "href": "researchers/index.html#research-team",
    "title": "Researchers",
    "section": "",
    "text": "Principal Investigator: Adam Hulman, Associate Professor at the Department of Public Health, Aarhus University & Senior Data Scientist at Steno Diabetes Center Aarhus\nPhD Student: Manuel Thomasen, Steno Diabetes Center Aarhus & Department of Public Health, Aarhus University\nAffiliated Lab: Machine Learning and Clinical Prediction HulmanLab, Steno Diabetes Center Aarhus."
  },
  {
    "objectID": "researchers/index.html#publications-and-resources",
    "href": "researchers/index.html#publications-and-resources",
    "title": "Researchers",
    "section": "",
    "text": "Preprint manuscripts will be available on [medRxiv / arXiv links].\nCode will be shared via GitHub.\n[Add links to relevant previous publications by team members.]"
  },
  {
    "objectID": "researchers/index.html#contact",
    "href": "researchers/index.html#contact",
    "title": "Researchers",
    "section": "",
    "text": "For questions or collaboration opportunities, please contact:\nAdam Hulman, Associate Professor\nadahul@rm.dk\nManuel Thomasen\nmanuth@rm.dk / manuth@ph.au.dk\nWe welcome researchers interested in digital health, vocal biomarkers, and diabetes epidemiology to reach out for collaboration or discussion."
  },
  {
    "objectID": "researchers/index.html#supported-by",
    "href": "researchers/index.html#supported-by",
    "title": "Researchers",
    "section": "",
    "text": "This work was supported by a research grant from the Danish Diabetes and Endocrine Academy, funded by the Novo Nordisk Foundation (NNF22SA0079901), and the Danish Data Science Academy, funded by the Novo Nordisk Foundation (NNF21SA0069429), and by Steno Diabetes Center Aarhus which is partly funded by a donation from the Novo Nordisk Foundation (NNF17SA0031230), and by a Data Science Emerging Investigator grant (NNF22OC0076725) by the Novo Nordisk Foundation, and funds by Aarhus University, Department of Public Health."
  }
]